Electric Vehicle Charging Station Placement: Formulation, Complexity, and Solutions

To enhance environmental sustainability, many countries will electrify their transportation systems in their future smart city plans. So the number of electric vehicles (EVs) running in a city will grow significantly. There are many ways to re-charge EVs' batteries and charging stations will be considered as the main source of energy. The locations of charging stations are critical; they should not only be pervasive enough such that an EV anywhere can easily access a charging station within its driving range, but also widely spread so that EVs can cruise around the whole city upon being re-charged. Based on these new perspectives, we formulate the Electric Vehicle Charging Station Placement Problem (EVCSPP) in this paper. We prove that the problem is non-deterministic polynomial-time hard. We also propose four solution methods to tackle EVCSPP and evaluate their performance on various artificial and practical cases. As verified by the simulation results, the methods have their own characteristics and they are suitable for different situations depending on the requirements for solution quality, algorithmic efficiency, problem size, nature of the algorithm, and existence of system prerequisite.Comment: Submitted to IEEE Transactions on Smart Grid, revise

Effects of severity of the residual stenosis of the infarct-related coronary artery on left ventricular dilation and function after acute myocardial infarction

AbstractObjectives. This study was designed to evaluate the relation between the severity of the residual stenosis of the infarct-related artery and changes in left ventricular volume and function after a first anterior myocardial infarction.Background. Although thrombolytic therapy improves clinical outcome after acute myocardial infarction, the relations between the severity of the residual stenosis of the infarct-related artery and postinfarction left ventricular remodeling and function are unclear.Methods. Fifty-eight patients with a first anterior myocardial infarction and significant disease only in the left anterior descending coronary artery on arteriography performed after 7 to 10 days were evaluated. All patients received thrombolytic therapy. Residual stenosis of the infarct-related artery was measured with quantitative coronary arteriography. Left ventricular volumes and ejection fraction were measured by echocardiography and radionuclide angiography, respectively, 7 to 10 days, 6 months and 1 year after infarction. End-diastolic and end-systolic left ventricular volumes were measured by two-dimensional echocardiography and normalized to body surface area. Patients were classified into three groups according to baseline residual stenosis severity: total occlusion (Group I), minimal lesion diameter <15 mm (Group II) and minimal diameter ≥1.5 mm (Group III).Results. Group I patients had significantly greater left ventricular end-diastolic and end-systolic volumes at 6 months and 1 year than did the other groups. Group II patients had greater end diastolic and end-systolic volumes than did Group III patients at 1 year. In addition, Group 1 patients had a lower ejection fraction at 1 year than that of the other groups. The minimal lesion diameter was significantly correlated with percent change in end-diastolic volume at 1 year.Conclusions. The severity of the baseline residual stenosis of the infarct-related artery is an important predictor of change in left ventricular volumes in the 1st year after infarction. Tolal occlusion of the infarct-related artery is associated with greater left ventricular dilation and functional impairment

ZOS: A Fast Rendezvous Algorithm Based on Set of Available Channels for Cognitive Radios

Most of existing rendezvous algorithms generate channel-hopping sequences based on the whole channel set. They are inefficient when the set of available channels is a small subset of the whole channel set. We propose a new algorithm called ZOS which uses three types of elementary sequences (namely, Zero-type, One-type, and S-type) to generate channel-hopping sequences based on the set of available channels. ZOS provides guaranteed rendezvous without any additional requirements. The maximum time-to-rendezvous of ZOS is upper-bounded by O(m1*m2*log2M) where M is the number of all channels and m1 and m2 are the numbers of available channels of two users.Comment: 10 page

Electrodynamics of Media

Contains reports on four research projects.Joint Services Electronics Program (Contract DAAB07-74-C-0630)California Institute of Technology (Contract 953524

Delayed diagnosis of 22q11.2 deletion syndrome in an adult Chinese lady

We report a 32 year-old Chinese lady with history of tetralogy of Fallot, presented to us with chest pain due to hypocalcemia secondary to hypoparathyroidism. With her dysmorphic facial features and intellectual disability 22q11.2 deletion was suspected and confirmed by genetic study. Clinicians should consider the diagnosis of DiGeorge syndrome in adult patient with past medical history of congenital heart disease, facial dysmorphism, intellectual disability and primary hypoparathyroidism.published_or_final_versio

Souvenaid in the Management of Mild Cognitive Impairment: An Expert Consensus Opinion

Background Mild cognitive impairment (MCI) among an aging global population is a growing challenge for healthcare providers and payers. In many cases, MCI is an ominous portent for dementia. Early and accurate diagnosis of MCI provides a window of opportunity to improve the outcomes using a personalized care plan including lifestyle modifications to reduce the impact of modifiable risk factors (for example, blood pressure control and increased physical activity), cognitive training, dietary advice, and nutritional support. Souvenaid is a once-daily drink containing a mixture of precursors and cofactors (long-chain omega-3 fatty acids, uridine, choline, B vitamins, vitamin C, vitamin E, and selenium), which was developed to support the formation and function of neuronal membranes and synapses. Healthcare providers, patients, and carers require expert advice about the use of Souvenaid. Methods An international panel of experts was convened to review the evidence and to make recommendations about the diagnosis and management of MCI, identification of candidates for Souvenaid, and use of Souvenaid in real-world practice. This article provides a summary of the expert opinions and makes recommendations for clinical practice and future research. Summary of opinion Early diagnosis of MCI requires the use of suitable neuropsychological tests combined with a careful clinical history. A multimodal approach is recommended; dietary and nutritional interventions should be considered alongside individualized lifestyle modifications. Although single-agent nutritional supplements have failed to produce cognitive benefits for patients with MCI, a broader nutritional approach warrants consideration. Evidence from randomized controlled trials suggests that Souvenaid should be considered as an option for some patients with early Alzheimer’s disease (AD), including those with MCI due to AD (prodromal AD). Conclusion Early and accurate diagnosis of MCI provides a window of opportunity to improve the outcomes using a multimodal management approach including lifestyle risk factor modification and consideration of the multinutrient Souvenaid